Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology. Novosanis currently has two devices (platforms) in portfolio: VAX-ID, suited for accurate intradermal injections and Colli-Pee, suited for standardized and volumetric collection of first void (first catch) urine.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Colli-Pee Small Volumes
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):